- Home
- Products
- Customized FluoroAb™
- LY6E
- Anti-LY6E MAb (Clone 1)-iFluor® 532 Succinimidyl Ester
Anti-LY6E MAb (Clone 1)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12694)
This product is comprised of an Anti-LY6E antibody (Clone 1) labeled with iFluor® 532 Succinimidyl Ester. iFluor® 532 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- LY6E
- Overview
- Anti-LY6E antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 532 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 537/560
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS12694. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-305 | Anti-LY6E-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CA6 MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5084)
- Anti-CD22 MAb (Clone 29)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2420)
- Anti-CCL11 MAb (Clone 2)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10061)
- Anti-SELL MAb (Clone 3)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15327)
- Anti-CD3E MAb (Clone 15)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16512)
- Anti-CD19 MAb (Clone 13)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3911)
- Mogamulizumab-iFluor 350 (CAT#: ADC-FL-325)
- Anti-TACSTD2 MAb (Clone 2)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15768)
- Anti-HAVCR1 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8136)
- Anti-TNFSF4 MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7692)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
